INOD Innodata Inc

Previous close
$94.71
Est. 12 months change
+5.83%
Projected Price
$100.29

Profitability Metrics

Return on Equity (ROE)
39.15%
Return on Assets (ROA)
21.47%
Return on Invested Capital (ROIC)
127.28%
Weighted Average Cost of Capital (WACC)
19.00%
ROIC - WACC
108.28%
Updated : 2026-05-20 19:07 ET

Valuation Metrics

P/E Ratio
84.86
Forward P/E
101.98
PEG Ratio
-
Debt Current Ratio
2.49

Growth & Cash Flow

Gross Margin
41.23%
Operating Margin
17.11%
FCF Margin
21.89%
TTM Revenue Growth
54.42%
Projected 12M EPS Growth
-16.78%

Price Change

Price % from 50 SMA
-14.61%
Price % from 200 SMA
-27.65%
6 Months
-55.99%
1 Year
1.64%
2 Years
469.08%
Click here to see the list of ETFs containing INOD as a top holding :Innodata Inc ETFs

Analysis

Company Overview

Innodata is a digital services and technology company providing AI-enabled data annotation, content engineering, and digital transformation services to enterprise and publishing clients. Sector: Technology.

Overview

Innodata Inc (INOD) is an individual stock. The analysis below presents key financial metrics for the company, covering profitability, capital efficiency, valuation, margins, and growth.

Profitability & Capital Efficiency

On the question of capital productivity, ROIC is 127.28%, WACC is 19.00%, and the economic spread is 108.28%. On balance, the spread between returns and capital costs is exceptional, meaning reinvested capital is creating significant incremental value at the company level. Supporting metrics show ROE at 39.15% and ROA at 21.47%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a company with credible compounding capacity if current operating execution persists.

Valuation

From a market pricing perspective, trailing P/E of 84.86, forward P/E of 101.98. With trailing and forward P/E closely aligned, the market appears to be pricing the company on the assumption that earnings remain broadly stable near term. The company carries an aggregate current ratio of 2.49, consistent with adequate near-term liquidity management. The overall valuation picture is one where the market is paying for a specific earnings and growth outcome — and where any deviation from that path would likely pressure multiples.

Margins & Cash Generation

The margin stack reads as follows: gross margin sits at 41.23%, operating margin at 17.11%, and free cash flow margin at 21.89%. The gross margin reading points to the company with solid but not outsized pricing power relative to direct costs. The company's operating margins are solid, pointing to overhead management that appears to be a relative strength. FCF margins are constructive here, reflecting the company that generate cash reliably after reinvestment requirements. The profile is not weak, but it is uneven enough that execution and cost control remain central to the forward case.

Growth & Forward Outlook

Where growth and expectations intersect, the estimated 12-month price change of 5.89%, where analyst estimates suggest only incremental upside absent a positive surprise, while TTM revenue growth of 54.42% suggesting the company is collectively capturing meaningful market share or pricing power. The forward EPS growth estimate of -16.8% is negative, which complicates the valuation case and suggests current multiples may not be as defensible on a forward basis. Both signals are useful lenses, but they tend to diverge most sharply near inflection points in both business fundamentals and market sentiment. The durability of both the operating trend and analyst optimism will determine whether the current setup translates into measurable near-term returns. The estimated 12-month price change is based on analyst consensus price target estimates, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.

Conclusion

Buy

The overall evidence base is constructive, with more signals pointing up than down and no obvious structural impairment to the forward case.

This assessment is based solely on the quantitative metrics presented above and does not constitute financial advice. Investors should consider their own risk tolerance and conduct independent research before making investment decisions.